Acton Pharmaceuticals
About Us Products Business Development News Careers Contact Us

BOARD OF DIRECTORS

John W. Simon
Chief Executive Officer
John Simon is a co-founder and Director of Acton Pharmaceuticals and also serves as its Chief Executive Officer. Prior to Acton, Mr. Simon spent 10 years at Sepracor Inc. where he served as Vice President, Respiratory Marketing.  During his tenure, Mr. Simon launched and led Sepracor largest revenue producing franchise with cumulative revenues of $2 billion. Prior to that, Mr. Simon was a marketing executive with Forest Laboratories from 1991 to 1997.  John is a co-founder of Forge Therapeutics, LLC, a pre-clinical stage, small molecule biopharmaceutical company focused on cardiovascular disease. He has also served as an advisor to venture capital funds and early stage pharmaceutical companies.  John received his B.A. degree from the University of Kentucky.

Daniel L. Kreisler
President and Chief Operating Officer
Daniel Kreisler is co-founder of Acton Pharmaceuticals, serves as its President and Chief Operating Officer and is a member of the Acton Board of Directors. Prior to Acton, Mr. Kreisler was a co-founder of JDS Pharmaceuticals, LLC, a specialty pharmaceutical company formed in 2004 where he held the position of Vice President, Business Development. In 2007, JDS was acquired by Noven Pharmaceuticals, Inc. for $125 million. Dan remained with Noven as Vice President, Business Development until mid-2009. Dan is a specialty pharmaceutical industry veteran with over 25 years of experience. Prior to co-founding Acton and JDS, Dan was co-founder of Krele Pharmaceuticals. Prior to that, Dan spent over 16 years at Forest Laboratories where he held positions in marketing management and business development. Dan holds a B.S. degree in Pharmacy from the University of Rhode Island.

Scott Carter
General Partner, Sequoia Capital
Scott is a general partner at Sequoia Capital.  Scott led Sequoia's investments in two healthcare companies, Ameritox and eCardio Diagnostics.  He also serves on the board of Merlin Securities, a leading independent prime broker.  Earlier, Scott was with JPMorgan and served in various staff positions in the United States Senate. Scott has a BA in Political Science from Texas A&M University and an MBA from the Darden School of Business at the University of Virginia.